US Stock Movement | Vertex Pharmaceuticals (VRTX.US) surges after hours as late-stage trial of kidney drug povetacicept meets expected targets
Show original
Previously, this biotechnology company announced that its drug for treating kidney disease met the expected targets in late-stage trials, injecting momentum into its strategy to go beyond cystic fibrosis treatments. As of Monday's close, the company's stock price has risen 1.7% so far this year.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Pudgy Penguins launches browser-based free game Pudgy World
PANews•2026/03/10 01:46
Bitcoin rises 4.3% to around $69,100 as the market shows initial signs of improvement
AIcoin•2026/03/10 01:40
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$69,204.88
+4.16%
Ethereum
ETH
$2,019.22
+3.41%
Tether USDt
USDT
$1
+0.02%
BNB
BNB
$638.55
+3.57%
XRP
XRP
$1.37
+1.80%
USDC
USDC
$1.0000
+0.00%
Solana
SOL
$85.7
+3.92%
TRON
TRX
$0.2857
-1.32%
Dogecoin
DOGE
$0.09100
+1.41%
Cardano
ADA
$0.2582
+2.68%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now